Clinical Trials Directory

Trials / Unknown

UnknownNCT02353650

The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a randomised double-blinded trial. A group of 40 tinnitus patients with a naturally low Q10 level will be selected out of a preselected group of 160 screened out of a pre-existed database or patients which visited the ENT-consultation. The 40 patients with the lowest level will be asked to take 2 months Q10 (n=20) or the placebo (n=20). To evaluate the effect on hearing and tinnitus characteristic; audiometric test, tinnitus analysis and auditory evoked responses will be used as outcome measurements.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTQ10
DIETARY_SUPPLEMENTplacebo

Timeline

Start date
2014-11-01
Primary completion
2016-06-01
First posted
2015-02-03
Last updated
2016-04-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02353650. Inclusion in this directory is not an endorsement.

The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients (NCT02353650) · Clinical Trials Directory